Piers Nash

Lunenfeld-Tanenbaum Research Institute

Papers

1

Total Citations

70

H-Index

1

About

Piers Nash is a molecular biologist whose research has significantly advanced our understanding of receptor tyrosine kinase (RTK) signaling, particularly within the Eph receptor family. His work illuminates how subtle molecular interactions can dramatically rewire cellular communication networks. In his highly cited 2003 study (70 citations), Nash demonstrated that manipulating specific regulatory motifs and SH2 binding sites on the EphB2 receptor could switch downstream MAPK signaling and alter biological outcomes. This pivotal finding revealed that Eph receptors are not simple on-off switches but sophisticated signal processors, capable of integrating multiple inputs to produce distinct cellular responses. By showing how activated EphB2 recruits p120RasGAP in neuronal cells, Nash provided mechanistic insight into how the same receptor can trigger different pathways depending on cellular context. His contributions have been foundational for researchers studying neuronal development, cancer biology, and signal transduction, offering a framework for understanding how signaling specificity is achieved through precise protein-protein interactions.

Research Focus

Key Achievements

1
H-Index
1
Papers
70
Total Citations
70
Avg Citations/Paper
🏆 Most Cited Paper
Manipulation of EphB2 Regulatory Motifs and SH2 Binding Sites Switches MAPK Signaling and Biological Activity
70 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Lunenfeld-Tanenbaum Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago